To validate the mRNA profiling and Hub gene identification results, the expression of the Hub mRNAs above was screened by quantitative real-time polymerase chain reaction with NSC/NPC samples used in RNA-Seq (six NC mice and six HE mice). This evidence concerns the gene ELAVL2 and nasopharyngeal carcinoma.